Key Takeaways
- • MegaRobo Technologies raised nearly $200 million in a funding round that included Oman Investment Authority, the Omani sovereign wealth fund, alongside CMB International and existing investors Asia Investment Capital, Granite Asia and Sinovation Ventures, according to a company statement issued Thursday, Nov. 19.
- • The Beijing-headquartered AI for Science (AI4S) company, founded in 2016, serves more than 1,200 pharmaceutical firms, biotech companies and academic institutions, with about 80% of revenue generated domestically.
- • MegaRobo has raised roughly $600 million across multiple rounds, including a near-$300 million Series C in June 2022 co-led by Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia that lifted its valuation above $1 billion.
- • Proceeds will fund core technology development, infrastructure for AI operating in complex environments, and expansion across Europe, North America, the Middle East and Asia.
- • CEO Daniel Huang told Bloomberg the company sees a "great deal" of overseas opportunity along Belt and Road markets, and said MegaRobo remains in the queue for a Hong Kong IPO after filing in mid-2025.
Summary
Founded in 2016 in Beijing, MegaRobo describes itself as an AI for Science (AI4S) company, using machine learning, deep learning and AI agents to accelerate scientific discovery. Its AI4S infrastructure integrates AI, scientific computing, experimental execution, data management and R&D decision-making. The business rests on two core lines: automating laboratory workflows to speed drug screening and target discovery, and deploying high-precision sensing and robotics to improve production yields for semiconductor, optical interconnect and display manufacturers.
The company serves more than 1,200 pharmaceutical firms, biotech companies and academic institutions, and currently generates about 80% of its revenue domestically. Founder and CEO Daniel Huang told Bloomberg that MegaRobo sees a "great deal" of overseas growth potential, particularly across Belt and Road markets. Proceeds from the new round will support continued investment in core technology and expansion across Europe, North America, the Middle East and Asia.
MegaRobo has raised about $600 million across multiple rounds to date. Its near-$300 million Series C, co-led by Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia in June 2022, pushed its valuation past $1 billion. Huang noted that the company remains in the queue for a Hong Kong initial public offering after filing in mid-2025.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.